My watch list
my.chemeurope.com  
Login  

Stanford V



Stanford V is a chemotherapy regimen designed for Hodgkin's lymphoma that consists of the following:

Additional recommended knowledge

It is a newer method than MOPP or ABVD, the two previous most common treatments for Hodgkin's lymphoma.

The chemotherapy part of Stanford V treatment can last anywhere from 8 to 12 weeks, depending on the staging of the disease. In many cases, this is followed by radiation therapy for anywhere from 2 to 6 weeks to the affected areas of the body.

It is believed that Stanford V is at least as effective as other methods of treatment. Stanford V is a more rigorously administered form of chemotherapy, with treatments roughly twice as fast as those of other Hodgkin's lymphoma treatments; however, this is tempered by the need for radiation therapy in most cases which is not typically required under ABVD.


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Stanford_V". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE